Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Green technology to boost production of malaria ‘wonder drug’

12.02.2007
New technologies that make the large-scale extraction of a natural antimalarial ‘wonder drug’ both cheaper and greener are to be developed and trialled in a new European effort.

Since it was first extracted from the herb Sweet Wormwood (Artemisia annua) by Chinese scientists in the 1980s, artemisinin has proven to be a potent anti-malarial treatment.

Most patients treated with Artemisinin-based Combination Treatments (ACTs) show clinical improvement within 24 hours.

However, large-scale production of artemisinin drugs, which are used as part of a combination therapy to avoid development of resistance by malaria parasites, has so far relied on extraction technology based on the petroleum derived hexane - a toxic and potentially explosive substance.

... more about:
»Artemisia »Artemisinin »Malaria »annua »hexane »solvent

In a search for a better extraction system, a team of chemical engineers from the University of Bath (UK) and a specialist UK business, FSC Development Services Ltd, were commissioned (in 2005) by the non-profit Medicines for Malaria Venture (MMV) and the Dutch Government to evaluate a range of new technologies that could replace hexane extraction, and make large-scale production both cheaper and more environmentally friendly.

In research published in the Journal of Natural Products, Dr Alexei Lapkin from the University’s Department of Chemical Engineering highlights three extraction processes that can compete with hexane extraction economically, as well as being better for the environment.

Now, using a £500,000 grant from the Dutch Government through MMV, some of these technologies will be demonstrated and tested over the next 12 months by a consortium of European companies and universities.

“Increased production of Artemisia annua is now happening in many countries around the world, but if we are to reduce the costs of the final drugs we need to increase yield through higher yielding varieties and introduce new, more efficient, safer and more environmentally friendly extraction systems,” said Dr Lapkin.

“The intention for this project is to build a small-scale demonstrator unit in Bath and prove its viability by extracting artemisinin from Artemisia annua plants grown in different countries and regions.

“The project will also explore purification methods of raw extracts to obtain material of good enough quality for pharmaceutical companies to buy for further processing into drug treatments.

“Our focus is on driving down the cost of extraction to help make this ‘wonder drug’ more readily available to the people who need it.”

Artemisinin is extracted from the Artemisia annua plant using a solvent which helps separate the different parts of the plant. The raw artemisinin is then purified to produce the final drug.

The most common solvent used in the current extraction process is hexane, an alkane hydrocarbon produced from crude oil that is both toxic and explosive, making it damaging to the environment and expensive to handle safely.

The research team examined alternative extraction technologies using either supercritical carbon dioxide (scCO2), hydrofluorocarbon HFC-134a, ionic liquids (ILs) or ethanol as alternative solvents. In this initial study they used data provided by technology developers in the UK, and compared it with the known data for hexane extraction.

They found that the technologies using scCO2, HFC and ILs, all of which are non-flammable solvents, gave faster extraction times and a more complete extraction of the useful substances in the leaf.

These solvents are also considerably safer, with no risk of explosions, and were much greener, having a lower environmental impact in use, and offering the potential for biodegradability after use.

Ionic liquid and HFC-134a technologies in particular showed considerable promise, and the analysis suggests that they could compete with hexane extraction in terms of cost-effectiveness.

Over the next nine months, a demonstrator unit using HFC-134a will be built at the University of Bath in collaboration with Ineos Fluor (UK). Bioniqs Ltd, a spin-off company from University of York (UK), will continue their work on ionic liquids extraction, and University of Bremen (Germany) will be testing extraction with another widely used solvent, ethanol.

The whole project is being co-ordinated by FSC Development Services Ltd, which is based in Gloucestershire (UK).

“MMV is pleased to support this project even though it is not our traditional line of work, as the focus is purely on technology rather than developing new drugs or treatments,” said Dr Ian Bathurst, Director of Drug Discovery & Technology at MMV.

“Developing technology that makes the extraction process as efficient and cost-effective as possible makes the mass production of artemisinin economically, environmentally and socially viable. This will have a significant impact on the new ACTs we are developing.”

Malcom Cutler, head of FSC Development Services Ltd., said: “This project is not about profit for companies; tackling malaria is not a business, but a challenge we must do everything we can to overcome.”

As the plasmodium parasite which causes malaria is able to mutate and develop resistance to the drugs used against it, it is important to have a variety of treatments available and to continue developing new medicines.

Andrew McLaughlin | alfa
Further information:
http://www.bath.ac.uk/news/2007/2/12/artemisia.html

Further reports about: Artemisia Artemisinin Malaria annua hexane solvent

More articles from Life Sciences:

nachricht Discovery of a Key Regulatory Gene in Cardiac Valve Formation
24.05.2017 | Universität Basel

nachricht Carcinogenic soot particles from GDI engines
24.05.2017 | Empa - Eidgenössische Materialprüfungs- und Forschungsanstalt

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

Im Focus: Using graphene to create quantum bits

In the race to produce a quantum computer, a number of projects are seeking a way to create quantum bits -- or qubits -- that are stable, meaning they are not much affected by changes in their environment. This normally needs highly nonlinear non-dissipative elements capable of functioning at very low temperatures.

In pursuit of this goal, researchers at EPFL's Laboratory of Photonics and Quantum Measurements LPQM (STI/SB), have investigated a nonlinear graphene-based...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

Physicists discover mechanism behind granular capillary effect

24.05.2017 | Physics and Astronomy

Measured for the first time: Direction of light waves changed by quantum effect

24.05.2017 | Physics and Astronomy

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>